Genius Sports Limited (NYSE: GENI) stock jumped 4.31% on Monday to $5.33 against a previous-day closing price of $5.11. With 1.47 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.79 million shares. During the session, the Internet Content & Information company that operates in wider Communication Services sector, reached to the highest price of $5.45 whereas the lowest price it dropped to was $5.13. The 52-week range on GENI shows that it touched its highest point at $8.45 and its lowest point at $3.12 during that stretch. It currently has a 1-year price target of $8.95. Beta for the stock currently stands at 1.98.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of GENI was up-trending over the past week, with a rise of 3.70%, but this was up by 6.60% over a month. The stock gained 18.71% in the past year, while it has gained 49.30% so far this year. A look at the trailing 12-month EPS for GENI yields -0.86 with Next year EPS estimates of -0.12. For the next quarter, that number is -0.07. This implies an EPS growth rate of 67.89% for this year and 58.06% for next year.
Float and Shares Shorts:
At present, 201.85 million GENI shares are outstanding with a float of 126.16 million shares on hand for trading. On Oct 30, 2023, short shares totaled 7.17 million, which was 3.05% higher than short shares on Sep 28, 2023. In addition to Mr. Mark Locke as the firm’s Co-Founder, CEO & Director, Mr. Nicholas Taylor serves as its Chief Financial Officer.
Institutional Ownership:
Other institutions hold 39.69% of GENI, in contrast to 13.46% held by mutual funds. As the largest shareholder in GENI with 9.48% of the stake, Caledonia holds 20,526,210 shares worth 20,526,210. A second-largest stockholder of GENI, Granahan Investment Management, L, holds 14,404,297 shares, controlling over 6.65% of the firm’s shares. Nikko Asset Management Americas, is the third largest shareholder in GENI, holding 7,047,580 shares or 3.25% stake. With a 2.80% stake in GENI, the ARK Next Generation Internet ETF is the largest stakeholder. A total of 6,072,243 shares are owned by the mutual fund manager. The MFS New Discovery Fund, which owns about 1.35% of GENI stock, is the second-largest Mutual Fund holder. It holds 2,915,388 shares valued at 14.23 million. Granahan Funds Plc – US Focused G holds 0.93% of the stake in GENI, owning 2,003,731 shares worth 9.78 million.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for GENI since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With GENI analysts setting a high price target of $12.00 and a low target of $7.00, the average target price over the next 12 months is $8.95. Based on these targets, GENI could surge 125.14% to reach the target high and rise by 31.33% to reach the target low. Reaching the average price target will result in a growth of 67.92% from current levels.
Summary of Insider Activity:
Insiders traded GENI stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has remained unchanged to 0 while that of sell transactions has remained unmoved to 0 over the past year. The total number of shares bought during that period was 0 while 0 shares were sold.
